Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
US-11034661-B2 · Jun 15, 2021 · US
This page is not indexed by search engines while we improve data quality.
Nargund Ravi patents
Nargund Ravi holds 9 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 9 |
| Recent patents | 0 |
| First publication | Dec 17, 2015 |
| Latest publication | Jun 15, 2021 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Long-acting co-agonists of the glucagon and GLP-1 receptors
US-10793615-B2 · Oct 6, 2020 · US
Long-acting co-agonists of the glucagon and glp-1 receptors
US-2019338008-A1 · Nov 7, 2019 · US
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C
US-9549921-B2 · Jan 24, 2017 · US
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis c
US-2016143895-A1 · May 26, 2016 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
US-11034661-B2 · Jun 15, 2021 · US
Long-acting co-agonists of the glucagon and GLP-1 receptors
US-10793615-B2 · Oct 6, 2020 · US
Long-acting co-agonists of the glucagon and glp-1 receptors
US-2019338008-A1 · Nov 7, 2019 · US
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C
US-9549921-B2 · Jan 24, 2017 · US
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis c
US-2016143895-A1 · May 26, 2016 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 9 |
| Chemistry & Metallurgy | 9 |
| Cross-Sectional Technologies | 1 |